Elevance Health, Inc.
ELV Healthcare Healthcare Plans
Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024. In the quarter to June 2026, revenue grew 1.40%, EPS fell 13.1%, free cash flow fell 9.01% and total debt rose 4.08%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.
Follow ELV
Elevance Health, Inc. (ELV) Price to free cash flow
As of 16 October 2026, Elevance Health, Inc. (ELV) trades at a price to free cash flow of 14.8×. Over the past ten years it has ranged from 6.2× (September 2020) to 159× (September 2024); the current reading is higher than 55% of that period. That is above the Healthcare Plans industry median of 11.8× and below the Healthcare sector median of 20.2×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 24.7× | 31.75% |
| FY2024 | 18.8× | 12.46% |
| FY2023 | 16.7× | 0.40% |
| FY2022 | 16.6× | 7.09% |
| FY2021 | 15.5× | 86.43% |
| FY2020 | 8.3× | (46.20%) |
| FY2019 | 15.5× | (40.18%) |
| FY2018 | 25.9× | 48.64% |
| FY2017 | 17.4× | 24.20% |
| FY2016 | 14.0× | 37.97% |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Jun 2026 | 13.3× | 33.76% |
| Mar 2026 | 10.0× | (59.68%) |
| Dec 2025 | 24.7× | 29.16% |
| Sep 2025 | 19.2× | 16.70% |
| 42 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| OSCR Oscar Health, Inc. compare | 2.2× |
| CNC Centene Corporation compare | 3.8× |
| CI Cigna Group compare | 8.7× |
| CVS CVS Health Corporation compare | 10.0× |
| ELV Elevance Health, Inc. | 14.8× |
| UNH UnitedHealth Group Incorporated compare | 15.9× |
| HUM Humana Inc. compare | 25.2× |
| CLOV Clover Health Investments, Corp. compare | 31.6× |
| MOH Molina Healthcare, Inc compare | 39.1× |
| Healthcare Plans industry median | 11.8× |
| Healthcare sector median | 20.2× |
| Market median | 14.2× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on ELV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement